Skip to main content
Top
Published in: Esophagus 3/2014

01-07-2014 | Original Article

Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy?

Authors: Harushi Udagawa, Masaki Ueno, Hisashi Shinohara, Shusuke Haruta, Seigi Lee, Kota Momose, Masahiko Tsurumaru

Published in: Esophagus | Issue 3/2014

Login to get access

Abstract

Background

Although dissection of mediastinal lymph nodes along the thoracic duct is included in standard radical esophagectomy, it is not routinely performed because of the undesirable hemodynamic effects. This study aims to investigate whether dissection of the nodes along the thoracic duct has prognostic benefits.

Methods

A total of 778 consecutive patients who underwent radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma of the thoracic esophagus from 1984 to 2011 were included. The incidence of metastasis in thoracic duct nodes and that in nodes within #112 station excluding thoracic duct nodes were studied in relation to the depth of the main tumor. The survival curves of lymph node-positive patients were compared.

Results

The metastatic incidence was 2.2 % in T1b/T2, whereas it was 10.0 % in T3/T4. The survival curves in patients with metastasis in the thoracic duct nodes and in the #112 station were not statistically different.

Conclusion

The dissection of the nodes along the thoracic duct along with thoracic duct resection should be performed routinely; however, reliable indicator of the necessity of its dissection is awaited in T1b/T2 tumors because of the low metastatic rate and the potential risk associated with resection of the thoracic duct.
Literature
1.
go back to reference Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef
2.
go back to reference Imamura M, Shimada Y, Kanda T, Miyahara T, Hashimoto M, Tobe T, et al. Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer. Surg Today. 1992;22(3):226–32.PubMedCrossRef Imamura M, Shimada Y, Kanda T, Miyahara T, Hashimoto M, Tobe T, et al. Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer. Surg Today. 1992;22(3):226–32.PubMedCrossRef
3.
go back to reference Fujita H. Surgical procedures and intra-operative management to prevent postoperative complications following resection of esophageal cancer. Nihon Geka Gakkai zasshi. 1996;97(6):421–6.PubMed Fujita H. Surgical procedures and intra-operative management to prevent postoperative complications following resection of esophageal cancer. Nihon Geka Gakkai zasshi. 1996;97(6):421–6.PubMed
4.
go back to reference Shiozaki H, Imamoto H, Shigeoka H, Imano M, Yano M. Minimally invasive esophagectomy with 10 cm thoracotomy assisted thoracoscopy for the thoracic esophageal cancer. Gan to kagaku ryoho. 2003;30(7):923–8.PubMed Shiozaki H, Imamoto H, Shigeoka H, Imano M, Yano M. Minimally invasive esophagectomy with 10 cm thoracotomy assisted thoracoscopy for the thoracic esophageal cancer. Gan to kagaku ryoho. 2003;30(7):923–8.PubMed
5.
go back to reference Udagawa H, Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus. 2001;14(2):110–4.PubMedCrossRef Udagawa H, Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus. 2001;14(2):110–4.PubMedCrossRef
6.
go back to reference Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, Nakagawa M, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106(6):742–7.PubMedCrossRef Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, Nakagawa M, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106(6):742–7.PubMedCrossRef
7.
go back to reference Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48(5):411–20.PubMedCrossRef Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48(5):411–20.PubMedCrossRef
8.
go back to reference Riddell AM, Davies DC, Allum WH, Wotherspoon AC, Richardson C, Brown G. High-resolution MRI in evaluation of the surgical anatomy of the esophagus and posterior mediastinum. Am J Roentgenol. 2007;188(1):W37–43.CrossRef Riddell AM, Davies DC, Allum WH, Wotherspoon AC, Richardson C, Brown G. High-resolution MRI in evaluation of the surgical anatomy of the esophagus and posterior mediastinum. Am J Roentgenol. 2007;188(1):W37–43.CrossRef
9.
go back to reference Murakami G, Sato I, Shimada K, Dong C, Kato Y, Imazeki T. Direct lymphatic drainage from the esophagus into the thoracic duct. Surg Radiol Anat. 1994;16(4):399–407.PubMedCrossRef Murakami G, Sato I, Shimada K, Dong C, Kato Y, Imazeki T. Direct lymphatic drainage from the esophagus into the thoracic duct. Surg Radiol Anat. 1994;16(4):399–407.PubMedCrossRef
10.
go back to reference Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat. 2007;29(7):531–42.PubMedCrossRef Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat. 2007;29(7):531–42.PubMedCrossRef
11.
go back to reference Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85(1):59–71.PubMed Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85(1):59–71.PubMed
12.
go back to reference Law S, Wong J. Lymph node dissection in surgical treatment of esophageal neoplasms. Surg Oncol Clin N Am. 2007;16:115–31.PubMedCrossRef Law S, Wong J. Lymph node dissection in surgical treatment of esophageal neoplasms. Surg Oncol Clin N Am. 2007;16:115–31.PubMedCrossRef
13.
go back to reference Mariette C, Piessen G. Oesophageal cancer: how radical should surgery be? Eur J Surg Oncol. 2012;38(3):210–3.PubMedCrossRef Mariette C, Piessen G. Oesophageal cancer: how radical should surgery be? Eur J Surg Oncol. 2012;38(3):210–3.PubMedCrossRef
14.
go back to reference Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Esophageal cancer. Curr Probl Surg. 1997;34(10):774–834.CrossRef Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Esophageal cancer. Curr Probl Surg. 1997;34(10):774–834.CrossRef
15.
go back to reference Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M. Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg. 1998;187(3):238–45.PubMedCrossRef Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M. Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg. 1998;187(3):238–45.PubMedCrossRef
Metadata
Title
Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy?
Authors
Harushi Udagawa
Masaki Ueno
Hisashi Shinohara
Shusuke Haruta
Seigi Lee
Kota Momose
Masahiko Tsurumaru
Publication date
01-07-2014
Publisher
Springer Japan
Published in
Esophagus / Issue 3/2014
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-014-0433-9

Other articles of this Issue 3/2014

Esophagus 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.